Today: 19 June 2026
Browse Category

Earnings Reports 13 January 2026

Kroger maintained its 2026 outlook after first-quarter sales exceeded forecasts, but adjusted earnings missed estimates by a cent. Shares fell in premarket trading due to margin pressure from price investments, higher transport costs, and changes in fuel mix. CarMax reported fiscal Q1 revenue of $8.01 billion, beating forecasts, driven by higher used-car prices and strong wholesale demand, though retail used-vehicle gross profit per unit declined and the company continued price cuts to boost sales. La-Z-Boy shares rebounded nearly 17% in after-hours trading after adjusted earnings beat expectations, with revenue flat year-over-year; retail expansion supported results, but same-store orders and Joybird sales remained weak. Micron Technology shares dropped 3.6% after a record close as semiconductor stocks slipped, with investors locking in profits rather than reacting to specific company news. Netflix shares declined amid deal speculation involving Roku and Lionsgate, with the next earnings date set for July 16; the stock’s outlook depends on ads, pricing, and engagement. AT&T shares dipped 1.23% before a slight premarket uptick, underperforming the broader market as telecom stocks were influenced more by rate changes than company news; its Q2 earnings call is upcoming. Dave & Buster’s shares fell 4.72% after earnings missed on revenue, profit, and comps, raising questions about future sales and free-cash-flow targets. Nokia shares dropped 3.32% in Helsinki after a recent surge, with its ADR slightly up in New York; the company is set to report soon. Ford shares lagged the S&P 500, with the company seeking to continue importing China-built Lincoln Nautilus as new U.S. rules for connected-car software approach.
DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom stock jumps in premarket after early Q4 sales and 2026 outlook; what DXCM investors watch next

DexCom shares rose about 5% premarket Tuesday after the company reported preliminary Q4 revenue of $1.26 billion, up 13% year over year, and issued 2026 guidance above prior expectations. U.S. sales reached $892 million, with international revenue at $368 million. The company reaffirmed 2025 margin targets and raised 2026 goals. Barclays downgraded DexCom, citing competitive pressures despite strong sales.
Unilever shares slip in London as Reuters flags India slowdown ahead of earnings

Unilever shares slip in London as Reuters flags India slowdown ahead of earnings

Unilever shares fell 0.22% to 4,760 pence in early London trading Tuesday. A Reuters column flagged weakening pricing power for Unilever and Nestlé in India, where local brands and delivery apps are eroding margins. Investors await Unilever’s Feb. 12 earnings for updates on growth and pricing. The company recently spun off its ice cream division as The Magnum Ice Cream Company.
SGX stock rises after report flags new Asian bond futures — what to watch into Feb. 5 results

SGX stock rises after report flags new Asian bond futures — what to watch into Feb. 5 results

Shares of Singapore Exchange Ltd rose 1.1% to S$17.71 Tuesday after a Bloomberg report said the bourse is in talks with global banks on launching bond futures tied to Asian government debt. The contracts would cover sovereign bonds from India, Indonesia, Malaysia, the Philippines, and Thailand, and may launch in early 2026. SGX will report first-half FY2026 results on Feb. 5.
CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL share price slips after ASX close: what investors watch next for ASX:CSL ahead of February results

CSL Ltd shares fell 1.0% to A$173.32 Tuesday, underperforming the S&P/ASX 200, which rose 0.56%. The drop follows last year’s cut to CSL’s FY26 forecasts and a delay to the Seqirus spin-off after a sharp decline in U.S. flu vaccinations. No new company updates were released Tuesday. CSL’s next scheduled disclosure is its half-year results on Feb. 11.
CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

CBA stock rises after new wage data — what to watch before Commonwealth Bank’s Feb results

Commonwealth Bank shares rose 0.8% to A$155.36 as major Australian banks advanced on renewed rate hike speculation. CBA’s wage tracker showed 0.8% quarterly pay growth and steady unemployment at 4.3%. The ASX 200 closed up 0.6%. Investors await CBA’s half-year results on Feb. 11 for margin and credit quality details.
Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments stock dips into CPI week as TXN heads toward earnings

Texas Instruments shares fell 0.7% to $189.07 on Monday, lagging behind record highs in the S&P 500 and Dow. Investors are watching Tuesday’s U.S. inflation data and Texas Instruments’ Jan. 27 earnings for signals on industrial demand. Semiconductor stocks showed mixed moves, with Qualcomm and Analog Devices posting steeper declines. The average analyst target for Texas Instruments stands at $190.40.
Wells Fargo stock slides as Trump’s credit-card cap talk hits banks ahead of earnings

Wells Fargo stock slides as Trump’s credit-card cap talk hits banks ahead of earnings

Wells Fargo shares fell about 1% to $94.96 on Monday after President Donald Trump proposed a one-year 10% cap on credit-card interest rates. The decline came ahead of the bank’s fourth-quarter earnings, due Wednesday morning. Analysts warned a rate cap could restrict credit access and hurt card profits. Broader financial stocks also retreated as traders watched for signs of policy risk and consumer strength.
GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

GE Aerospace stock heads into earnings week as Airbus flags engine delays and brokers tweak targets

GE Aerospace shares closed up 0.8% at $324.17 after Wolfe Research raised its price target, while Citi lowered its own but kept a Buy rating. Airbus warned that Pratt & Whitney engine deliveries remain “very, very late,” with delays now stretching into 2026. GE reports earnings Jan. 22. RTX shares rose 2.8%.
Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

Alnylam stock sinks nearly 7% after Amvuttra revenue miss; what to watch next for ALNY

Alnylam shares fell 6.7% to $370.91 after preliminary fourth-quarter sales for Amvuttra missed Wall Street estimates. The company reported about $827 million in Amvuttra revenue, below analyst expectations of $852 million. Alnylam set 2026 product revenue guidance at $4.9 billion to $5.3 billion and outlined a new five-year plan. Full results are due in February.
Coca-Cola stock barely moves after-hours with CPI hours away — what KO traders watch next

Coca-Cola stock barely moves after-hours with CPI hours away — what KO traders watch next

Coca-Cola shares closed at $70.47, nearly unchanged, and traded near $70.50 after hours Monday as investors awaited Tuesday’s U.S. inflation data. The company will report earnings Feb. 10 and transition to new CEO Henrique Braun on March 31. PepsiCo rose 1.04% to $141.36, outperforming Coca-Cola in the session. The S&P 500 and Dow hit record highs despite concerns over Fed independence.
Western Digital stock jumps nearly 6% as it sets Jan. 29 earnings — what traders watch next

Western Digital stock jumps nearly 6% as it sets Jan. 29 earnings — what traders watch next

Western Digital shares surged 5.8% to $212.14 in after-hours trading Monday, rebounding from a volatile session. The company will report fiscal Q2 results on Jan. 29, targeting revenue near $2.9 billion and non-GAAP EPS of about $1.88. Investors are watching for signs of continued AI and cloud demand. Seagate shares also rose 5.7% after announcing new 32-terabyte drive shipments.
Robinhood (HOOD) stock ends higher after Powell-Fed jitters; CPI and Feb. 10 earnings loom

Robinhood (HOOD) stock ends higher after Powell-Fed jitters; CPI and Feb. 10 earnings loom

Robinhood shares rose 1.9% to $117.52 Monday, trading steadily after hours as Wall Street closed at record highs. The session saw volatility after the Trump administration threatened to indict Fed Chair Jerome Powell and proposed a 10% cap on credit card rates. Robinhood’s earnings are due Feb. 10, with investors watching Tuesday’s U.S. inflation data. Crypto firm BitGo announced plans to go public at a $1.96 billion valuation.
Goldman Sachs stock edges up after hours as Trump credit-card cap risks collide with earnings week

Goldman Sachs stock edges up after hours as Trump credit-card cap risks collide with earnings week

Goldman Sachs shares rose 1.1% to $949.55 in after-hours trading Monday, after a session range of $927.40 to $950.55. The move comes as banks face scrutiny over Trump’s proposed 10% credit-card rate cap and ahead of Tuesday’s U.S. CPI report and bank earnings. Goldman expects the Apple Card transition to JPMorgan to boost Q4 2025 earnings by $0.46 per share.
1 147 148 149 150 151 257

Stock Market Today

  • SpaceX vs. S&P 500: Where to Invest $1,000 After SpaceX IPO
    June 19, 2026, 2:30 AM EDT. Following SpaceX's historic IPO and a 33% short-term gain, investors face a choice between SpaceX shares and the S&P 500 index. SpaceX's initial momentum is driven by limited public float and strong demand, but history shows post-IPO returns for similar companies often decline due to lock-up expirations releasing shares into the market, leading to average losses of 5.3% over three years. In contrast, the S&P 500, a broad market index representing 500 large U.S. companies, generally offers steadier returns with less risk. Though SpaceX may eventually become part of the S&P 500, the current wise choice for risk-averse investors aiming for long-term growth is to invest in an S&P 500 exchange-traded fund (ETF) rather than SpaceX stock.

Latest articles

Kardigan pops in first Nasdaq trading after $400 million IPO

Kardigan pops in first Nasdaq trading after $400 million IPO

19 June 2026
Kardigan surged 37.5% above its $16 IPO price to close at $22 after raising $400 million in an upsized Nasdaq debut, signaling renewed investor appetite for large biotech IPOs as the company advances three late-stage cardiovascular drug candidates.
Go toTop